English

Inari Medical, Inc.

EDGAR

NARI Quarterly report (10-Q) · filed 2024-10-28

22 filing records in this dataset, filed from 2020-02-21 to 2024-10-28. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

153 million USD

2024 Q3 · USD

Exact inputs and evidence

Revenue: 153390000 USD Source

Operating margin

-8.85%

2024 Q3 · %

Exact inputs and evidence

Operating Income: -13568000 USD Source
Revenue: 153390000 USD Source

Operating cash flow

2.71 million USD

2024 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 1937000 USD Source
Operating Cash Flow: -775000 USD Source

Free cash flow

-176 thousand USD

2024 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 1937000 USD Source
Operating Cash Flow: -775000 USD Source
Capital Expenditure: 7899000 USD Source
Capital Expenditure: 5011000 USD Source

Cash and cash equivalents: 41.1 million USD 2024-09-30 Source
Exact value

41141000 USD
Long-term debt including current maturities: 29.6 million USD 2020-06-30 Source
Exact value

29582000 USD
Shares outstanding: 58.4 million shares 2024-09-30 Source
Exact value

58435576 shares

Reported share-count change

1.62% · 929 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

57506462 shares · 2023-09-30· Source
58435576 shares · 2024-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

574 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence

Revenue: 493632000 USD · 2023-01-01 – 2023-12-31 Source
Revenue: 361538000 USD · 2023-01-01 – 2023-09-30 Source
Revenue: 143194000 USD · 2024-01-01 – 2024-03-31 Source
Revenue: 145820000 USD · 2024-04-01 – 2024-06-30 Source
Revenue: 153390000 USD · 2024-07-01 – 2024-09-30 Source

Net income

-78.6 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence

Net income: -1636000 USD · 2023-01-01 – 2023-12-31 Source
Net income: 3029000 USD · 2023-01-01 – 2023-09-30 Source
Net income: -24202000 USD · 2024-01-01 – 2024-03-31 Source
Net income: -31348000 USD · 2024-04-01 – 2024-06-30 Source
Net income: -18367000 USD · 2024-07-01 – 2024-09-30 Source

Operating cash flow

14.2 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence

Operating cash flow: 35927000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: 23686000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -12288000 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -775000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -12288000 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: 1937000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -775000 USD · 2024-01-01 – 2024-06-30 Source

Capital expenditure

8.81 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence

Capital expenditure: 4710000 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 3801000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 1250000 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 5011000 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 1250000 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 7899000 USD · 2024-01-01 – 2024-09-30 Source
Capital expenditure: 5011000 USD · 2024-01-01 – 2024-06-30 Source

Free cash flow

5.37 million USD

2023-10-01 – 2024-09-30

Exact inputs and evidence

Operating cash flow: 35927000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: 23686000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -12288000 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -775000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -12288000 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: 1937000 USD · 2024-01-01 – 2024-09-30 Source
Operating cash flow: -775000 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 4710000 USD · 2023-01-01 – 2023-12-31 Source
Capital expenditure: 3801000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 1250000 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 5011000 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 1250000 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 7899000 USD · 2024-01-01 – 2024-09-30 Source
Capital expenditure: 5011000 USD · 2024-01-01 – 2024-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-10-28.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2023-12-31
Operating income: 6 of 11 periods available· newest 2023-12-31
Net income: 6 of 11 periods available· newest 2023-12-31
Operating cash flow: 6 of 11 periods available· newest 2023-12-31
Capital expenditure: 6 of 11 periods available· newest 2023-12-31
Total assets: 5 of 11 periods available· newest 2023-12-31
Total liabilities: 5 of 11 periods available· newest 2023-12-31
Current assets: 5 of 11 periods available· newest 2023-12-31
Current liabilities: 5 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2023-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2019-12-31
Shares outstanding: 5 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+28.7%

Prior period

USD 383.47 million

2022-01-01 – 2022-12-31
Current period

USD 493.63 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

493632000 − 383471000 = 110161000 USD

383471000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
493632000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Inari Medical, Inc. · 2023-12-31 Inari Medical, Inc. (edgar:1531048) Year-over-year change in Revenue: 110161000 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 493632000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1373611 Filing: 000153104824000024 Input fundies:Revenue: 383471000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1374576 Filing: 000153104824000024
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 27.63 million

Prior period

−USD 29.27 million

2022-01-01 – 2022-12-31
Current period

−USD 1.64 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-1636000 − -29267000 = 27631000 USD

-29267000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-1636000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Inari Medical, Inc. · 2023-12-31 Inari Medical, Inc. (edgar:1531048) Year-over-year change in Net income: 27631000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1636000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#2012183 Filing: 000153104824000024 Input fundies:NetIncome: -29267000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#2012946 Filing: 000153104824000024
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 49.9 million

Prior period

−USD 13.97 million

2022-01-01 – 2022-12-31
Current period

USD 35.93 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

35927000 − -13972000 = 49899000 USD

-13972000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
35927000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Inari Medical, Inc. · 2023-12-31 Inari Medical, Inc. (edgar:1531048) Year-over-year change in Operating cash flow: 49899000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 35927000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1271629 Filing: 000153104824000024 Input fundies:OperatingCashFlow: -13972000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1272271 Filing: 000153104824000024
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-52.7%

Prior period

USD 9.95 million

2022-01-01 – 2022-12-31
Current period

USD 4.71 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

4710000 − 9951000 = -5241000 USD

9951000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
4710000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Inari Medical, Inc. · 2023-12-31 Inari Medical, Inc. (edgar:1531048) Year-over-year change in Capital expenditure: -5241000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 4710000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1274408 Filing: 000153104824000024 Input fundies:CapitalExpenditure: 9951000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1274992 Filing: 000153104824000024
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 493.63 million 100% of revenue
Cost of revenue USD 59.07 million 12% of revenue
Operating expenses USD 448.6 million 91% of revenue
Operating income −USD 14.03 million −2.8% of revenue
Tax, interest and other Derived −USD 12.4 million −2.5% of revenue
Net income −USD 1.64 million −0.3% of revenue

Cash

Operating cash flow USD 35.93 million 7.3% of revenue
Capital expenditure USD 4.71 million 1% of revenue
Free cash flow Derived USD 31.22 million 6.3% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2018 Operating loss: operating costs were 234% of revenue.
2019 Net loss: net income was −2.3% of revenue.
2020 9.9%87%
2021 96%
2022 Operating loss: operating costs were 107% of revenue.
2023 Operating loss: operating costs were 103% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2018 2018-01-01 – 2018-12-31	6829000	15969000 Derived	-9140000	1013000 Derived	-10153000	-11645000 Derived	Source 2018-01-01 – 2018-12-31: 6829000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -9140000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -10153000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -10892000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 753000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	51129000	50328000 Derived	801000	1993000 Derived	-1192000	-8080000 Derived	Source 2019-01-01 – 2019-12-31: 51129000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: 801000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -1192000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -4936000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 3144000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	139670000	121251000 Derived	18419000	4630000 Derived	13789000	-3548000 Derived	Source 2020-01-01 – 2020-12-31: 139670000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 18419000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 13789000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 1912000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 5460000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	276984000	266140000 Derived	10844000	1004000 Derived	9840000	11841000 Derived	Source 2021-01-01 – 2021-12-31: 276984000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 10844000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 9840000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 25486000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 13645000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	383471000	411570000 Derived	-28099000	1168000 Derived	-29267000	-23923000 Derived	Source 2022-01-01 – 2022-12-31: 383471000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -28099000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -29267000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -13972000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 9951000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	493632000	507664000 Derived	-14032000	-12396000 Derived	-1636000	31217000 Derived	Source 2023-01-01 – 2023-12-31: 493632000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -14032000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -1636000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 35927000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 4710000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 493.6M 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Revenue	6829000	Revenue: 6829000 Open source
20192019-12-31	Revenue	51129000	Revenue: 51129000 Open source
20202020-12-31	Revenue	139670000	Revenue: 139670000 Open source
20212021-12-31	Revenue	276984000	Revenue: 276984000 Open source
20222022-12-31	Revenue	383471000	Revenue: 383471000 Open source
20232023-12-31	Revenue	493632000	Revenue: 493632000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

28.7% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Year over year	No prior comparable period	Revenue: 6829000 Open source
20192019-12-31	Year over year	648.7%	Revenue: 51129000 Open source Revenue: 6829000 Open source
20202020-12-31	Year over year	173.2%	Revenue: 139670000 Open source Revenue: 51129000 Open source
20212021-12-31	Year over year	98.3%	Revenue: 276984000 Open source Revenue: 139670000 Open source
20222022-12-31	Year over year	38.4%	Revenue: 383471000 Open source Revenue: 276984000 Open source
20232023-12-31	Year over year	28.7%	Revenue: 493632000 Open source Revenue: 383471000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -2.8% 2023

Net margin -0.3% 2023

Free cash flow margin 6.3% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Operating margin	-133.8%	Operating Income: -9140000 Open source Revenue: 6829000 Open source
20192019-12-31	Operating margin	1.6%	Operating Income: 801000 Open source Revenue: 51129000 Open source
20202020-12-31	Operating margin	13.2%	Operating Income: 18419000 Open source Revenue: 139670000 Open source
20212021-12-31	Operating margin	3.9%	Operating Income: 10844000 Open source Revenue: 276984000 Open source
20222022-12-31	Operating margin	-7.3%	Operating Income: -28099000 Open source Revenue: 383471000 Open source
20232023-12-31	Operating margin	-2.8%	Operating Income: -14032000 Open source Revenue: 493632000 Open source
20182018-12-31	Net margin	-148.7%	Net Income: -10153000 Open source Revenue: 6829000 Open source
20192019-12-31	Net margin	-2.3%	Net Income: -1192000 Open source Revenue: 51129000 Open source
20202020-12-31	Net margin	9.9%	Net Income: 13789000 Open source Revenue: 139670000 Open source
20212021-12-31	Net margin	3.6%	Net Income: 9840000 Open source Revenue: 276984000 Open source
20222022-12-31	Net margin	-7.6%	Net Income: -29267000 Open source Revenue: 383471000 Open source
20232023-12-31	Net margin	-0.3%	Net Income: -1636000 Open source Revenue: 493632000 Open source
20182018-12-31	Free cash flow margin	-170.5%	Revenue: 6829000 Open source Operating Cash Flow: -10892000 Open source Capital Expenditure: 753000 Open source
20192019-12-31	Free cash flow margin	-15.8%	Revenue: 51129000 Open source Operating Cash Flow: -4936000 Open source Capital Expenditure: 3144000 Open source
20202020-12-31	Free cash flow margin	-2.5%	Revenue: 139670000 Open source Operating Cash Flow: 1912000 Open source Capital Expenditure: 5460000 Open source
20212021-12-31	Free cash flow margin	4.3%	Revenue: 276984000 Open source Operating Cash Flow: 25486000 Open source Capital Expenditure: 13645000 Open source
20222022-12-31	Free cash flow margin	-6.2%	Revenue: 383471000 Open source Operating Cash Flow: -13972000 Open source Capital Expenditure: 9951000 Open source
20232023-12-31	Free cash flow margin	6.3%	Revenue: 493632000 Open source Operating Cash Flow: 35927000 Open source Capital Expenditure: 4710000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 35.9M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Operating cash flow	-10892000	Operating Cash Flow: -10892000 Open source
20192019-12-31	Operating cash flow	-4936000	Operating Cash Flow: -4936000 Open source
20202020-12-31	Operating cash flow	1912000	Operating Cash Flow: 1912000 Open source
20212021-12-31	Operating cash flow	25486000	Operating Cash Flow: 25486000 Open source
20222022-12-31	Operating cash flow	-13972000	Operating Cash Flow: -13972000 Open source
20232023-12-31	Operating cash flow	35927000	Operating Cash Flow: 35927000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 31.2M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Free cash flow	-11645000	Operating Cash Flow: -10892000 Open source Capital Expenditure: 753000 Open source
20192019-12-31	Free cash flow	-8080000	Operating Cash Flow: -4936000 Open source Capital Expenditure: 3144000 Open source
20202020-12-31	Free cash flow	-3548000	Operating Cash Flow: 1912000 Open source Capital Expenditure: 5460000 Open source
20212021-12-31	Free cash flow	11841000	Operating Cash Flow: 25486000 Open source Capital Expenditure: 13645000 Open source
20222022-12-31	Free cash flow	-23923000	Operating Cash Flow: -13972000 Open source Capital Expenditure: 9951000 Open source
20232023-12-31	Free cash flow	31217000	Operating Cash Flow: 35927000 Open source Capital Expenditure: 4710000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

31% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2018-12-31	Liabilities / assets	Not reported	No source recorded
20192019-12-31	Liabilities / assets	66.3%	Total Liabilities: 29520000 Open source Total Assets: 44546000 Open source
20202020-12-31	Liabilities / assets	6.5%	Total Liabilities: 13838000 Open source Total Assets: 214092000 Open source
20212021-12-31	Liabilities / assets	23.2%	Total Liabilities: 72333000 Open source Total Assets: 311542000 Open source
20222022-12-31	Liabilities / assets	17.3%	Total Liabilities: 87150000 Open source Total Assets: 504152000 Open source
20232023-12-31	Liabilities / assets	31%	Total Liabilities: 209325000 Open source Total Assets: 674235000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.09× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2018-12-31	Current assets / current liabilities	Not reported	No source recorded
20192019-12-31	Current assets / current liabilities	4.44×	Current Assets: 39408000 Open source Current Liabilities: 8870000 Open source
20202020-12-31	Current assets / current liabilities	14.86×	Current Assets: 205673000 Open source Current Liabilities: 13838000 Open source
20212021-12-31	Current assets / current liabilities	5.77×	Current Assets: 245198000 Open source Current Liabilities: 42513000 Open source
20222022-12-31	Current assets / current liabilities	7.53×	Current Assets: 422905000 Open source Current Liabilities: 56174000 Open source
20232023-12-31	Current assets / current liabilities	3.09×	Current Assets: 235563000 Open source Current Liabilities: 76339000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2018 2018-01-01 – 2018-12-31	−USD 10.15 million Exact value Exact value: -10153000 USD 2018-01-01 – 2018-12-31: -10153000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Inari Medical, Inc. · 2018-12-31 Inari Medical, Inc. (edgar:1531048) Net Income: -10153000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10153000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000156459021011763/nari-20201231.xml#203890 Filing: 000156459021011763 The citation records this snapshot. The page link may show a newer release later.	−USD 10.89 million Exact value Exact value: -10892000 USD 2018-01-01 – 2018-12-31: -10892000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Inari Medical, Inc. · 2018-12-31 Inari Medical, Inc. (edgar:1531048) Operating Cash Flow: -10892000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10892000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000156459021011763/nari-20201231.xml#235507 Filing: 000156459021011763 The citation records this snapshot. The page link may show a newer release later.	USD 753,000 Exact value Exact value: 753000 USD 2018-01-01 – 2018-12-31: 753000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Inari Medical, Inc. · 2018-12-31 Inari Medical, Inc. (edgar:1531048) Capital Expenditure: 753000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 753000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000156459021011763/nari-20201231.xml#236139 Filing: 000156459021011763 The citation records this snapshot. The page link may show a newer release later.	−USD 11.65 million Calculation and evidence -10892000 − 753000 USD Exact free cash flow: -11645000 USD 2018-01-01 – 2018-12-31: -10892000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 753000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Inari Medical, Inc. · 2018-12-31 Inari Medical, Inc. (edgar:1531048) Free cash flow: -11645000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10892000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000156459021011763/nari-20201231.xml#235507 Filing: 000156459021011763 Input fundies:CapitalExpenditure: 753000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000156459021011763/nari-20201231.xml#236139 Filing: 000156459021011763 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 1.19 million Exact value Exact value: -1192000 USD 2019-01-01 – 2019-12-31: -1192000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Inari Medical, Inc. · 2019-12-31 Inari Medical, Inc. (edgar:1531048) Net Income: -1192000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1192000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000095017022001783/nari-20211231.htm#4221648 Filing: 000095017022001783 The citation records this snapshot. The page link may show a newer release later.	−USD 4.94 million Exact value Exact value: -4936000 USD 2019-01-01 – 2019-12-31: -4936000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Inari Medical, Inc. · 2019-12-31 Inari Medical, Inc. (edgar:1531048) Operating Cash Flow: -4936000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4936000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000095017022001783/nari-20211231.htm#2464086 Filing: 000095017022001783 The citation records this snapshot. The page link may show a newer release later.	USD 3.14 million Exact value Exact value: 3144000 USD 2019-01-01 – 2019-12-31: 3144000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Inari Medical, Inc. · 2019-12-31 Inari Medical, Inc. (edgar:1531048) Capital Expenditure: 3144000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3144000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000095017022001783/nari-20211231.htm#2474309 Filing: 000095017022001783 The citation records this snapshot. The page link may show a newer release later.	−USD 8.08 million Calculation and evidence -4936000 − 3144000 USD Exact free cash flow: -8080000 USD 2019-01-01 – 2019-12-31: -4936000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 3144000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Inari Medical, Inc. · 2019-12-31 Inari Medical, Inc. (edgar:1531048) Free cash flow: -8080000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4936000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000095017022001783/nari-20211231.htm#2464086 Filing: 000095017022001783 Input fundies:CapitalExpenditure: 3144000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000095017022001783/nari-20211231.htm#2474309 Filing: 000095017022001783 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 13.79 million Exact value Exact value: 13789000 USD 2020-01-01 – 2020-12-31: 13789000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Inari Medical, Inc. · 2020-12-31 Inari Medical, Inc. (edgar:1531048) Net Income: 13789000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 13789000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000095017023004675/nari-20221231.htm#4371662 Filing: 000095017023004675 The citation records this snapshot. The page link may show a newer release later.	USD 1.91 million Exact value Exact value: 1912000 USD 2020-01-01 – 2020-12-31: 1912000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Inari Medical, Inc. · 2020-12-31 Inari Medical, Inc. (edgar:1531048) Operating Cash Flow: 1912000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1912000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000095017023004675/nari-20221231.htm#2567689 Filing: 000095017023004675 The citation records this snapshot. The page link may show a newer release later.	USD 5.46 million Exact value Exact value: 5460000 USD 2020-01-01 – 2020-12-31: 5460000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Inari Medical, Inc. · 2020-12-31 Inari Medical, Inc. (edgar:1531048) Capital Expenditure: 5460000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5460000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000095017023004675/nari-20221231.htm#2578866 Filing: 000095017023004675 The citation records this snapshot. The page link may show a newer release later.	−USD 3.55 million Calculation and evidence 1912000 − 5460000 USD Exact free cash flow: -3548000 USD 2020-01-01 – 2020-12-31: 1912000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 5460000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Inari Medical, Inc. · 2020-12-31 Inari Medical, Inc. (edgar:1531048) Free cash flow: -3548000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1912000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000095017023004675/nari-20221231.htm#2567689 Filing: 000095017023004675 Input fundies:CapitalExpenditure: 5460000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000095017023004675/nari-20221231.htm#2578866 Filing: 000095017023004675 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 9.84 million Exact value Exact value: 9840000 USD 2021-01-01 – 2021-12-31: 9840000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Inari Medical, Inc. · 2021-12-31 Inari Medical, Inc. (edgar:1531048) Net Income: 9840000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 9840000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#2013710 Filing: 000153104824000024 The citation records this snapshot. The page link may show a newer release later.	USD 25.49 million Exact value Exact value: 25486000 USD 2021-01-01 – 2021-12-31: 25486000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Inari Medical, Inc. · 2021-12-31 Inari Medical, Inc. (edgar:1531048) Operating Cash Flow: 25486000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 25486000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1272917 Filing: 000153104824000024 The citation records this snapshot. The page link may show a newer release later.	USD 13.65 million Exact value Exact value: 13645000 USD 2021-01-01 – 2021-12-31: 13645000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Inari Medical, Inc. · 2021-12-31 Inari Medical, Inc. (edgar:1531048) Capital Expenditure: 13645000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13645000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1275577 Filing: 000153104824000024 The citation records this snapshot. The page link may show a newer release later.	USD 11.84 million Calculation and evidence 25486000 − 13645000 USD Exact free cash flow: 11841000 USD 2021-01-01 – 2021-12-31: 25486000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 13645000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Inari Medical, Inc. · 2021-12-31 Inari Medical, Inc. (edgar:1531048) Free cash flow: 11841000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 25486000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1272917 Filing: 000153104824000024 Input fundies:CapitalExpenditure: 13645000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1275577 Filing: 000153104824000024 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 29.27 million Exact value Exact value: -29267000 USD 2022-01-01 – 2022-12-31: -29267000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Inari Medical, Inc. · 2022-12-31 Inari Medical, Inc. (edgar:1531048) Net Income: -29267000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -29267000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#2012946 Filing: 000153104824000024 The citation records this snapshot. The page link may show a newer release later.	−USD 13.97 million Exact value Exact value: -13972000 USD 2022-01-01 – 2022-12-31: -13972000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Inari Medical, Inc. · 2022-12-31 Inari Medical, Inc. (edgar:1531048) Operating Cash Flow: -13972000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13972000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1272271 Filing: 000153104824000024 The citation records this snapshot. The page link may show a newer release later.	USD 9.95 million Exact value Exact value: 9951000 USD 2022-01-01 – 2022-12-31: 9951000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Inari Medical, Inc. · 2022-12-31 Inari Medical, Inc. (edgar:1531048) Capital Expenditure: 9951000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9951000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1274992 Filing: 000153104824000024 The citation records this snapshot. The page link may show a newer release later.	−USD 23.92 million Calculation and evidence -13972000 − 9951000 USD Exact free cash flow: -23923000 USD 2022-01-01 – 2022-12-31: -13972000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 9951000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Inari Medical, Inc. · 2022-12-31 Inari Medical, Inc. (edgar:1531048) Free cash flow: -23923000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13972000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1272271 Filing: 000153104824000024 Input fundies:CapitalExpenditure: 9951000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1274992 Filing: 000153104824000024 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 1.64 million Exact value Exact value: -1636000 USD 2023-01-01 – 2023-12-31: -1636000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Inari Medical, Inc. · 2023-12-31 Inari Medical, Inc. (edgar:1531048) Net Income: -1636000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1636000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#2012183 Filing: 000153104824000024 The citation records this snapshot. The page link may show a newer release later.	USD 35.93 million Exact value Exact value: 35927000 USD 2023-01-01 – 2023-12-31: 35927000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Inari Medical, Inc. · 2023-12-31 Inari Medical, Inc. (edgar:1531048) Operating Cash Flow: 35927000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 35927000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1271629 Filing: 000153104824000024 The citation records this snapshot. The page link may show a newer release later.	USD 4.71 million Exact value Exact value: 4710000 USD 2023-01-01 – 2023-12-31: 4710000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Inari Medical, Inc. · 2023-12-31 Inari Medical, Inc. (edgar:1531048) Capital Expenditure: 4710000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4710000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1274408 Filing: 000153104824000024 The citation records this snapshot. The page link may show a newer release later.	USD 31.22 million Calculation and evidence 35927000 − 4710000 USD Exact free cash flow: 31217000 USD 2023-01-01 – 2023-12-31: 35927000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 4710000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Inari Medical, Inc. · 2023-12-31 Inari Medical, Inc. (edgar:1531048) Free cash flow: 31217000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T17:15:30Z Snapshot: 8584cf069903416cc41881e8af308f4ab433f886df7f9fc24a8aea8744c83009 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1531048?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 35927000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1271629 Filing: 000153104824000024 Input fundies:CapitalExpenditure: 4710000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1531048/000153104824000024/nari-20231231.htm#1274408 Filing: 000153104824000024 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

22 filings · 1,712 latest values · 1,712 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001531048, 1531048, NARI, edgar:1531048

Also known as Inari Medical, Inc., Inceptus Newco1 Inc.

Inari Medical, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation